Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HCM NASDAQ:INDV TSE:ITH NASDAQ:SOPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHCMHUTCHMED$11.14+0.6%$11.40$9.77▼$19.50$1.93B0.2447,306 shs38,353 shsINDVIndivior$40.21-0.7%$38.59$15.00▼$42.81$4.94B0.861.78 million shs1.23 million shsITHInternational Tower Hill MinesC$2.98-2.0%C$3.24C$1.36▼C$4.94C$779.68M2.36183479,988 shs37,700 shsSOPHSOPHiA GENETICS$5.72+1.2%$5.18$2.92▼$6.30$474.01M0.96368,852 shs230,518 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHCMHUTCHMED+0.63%-4.38%+1.64%-26.76%-30.55%INDVIndivior-0.72%+0.55%+4.50%+21.96%+159.92%ITHInternational Tower Hill Mines-1.97%-13.12%+0.68%-16.29%+97.35%SOPHSOPHiA GENETICS+1.24%+7.12%+17.21%+15.32%+63.90%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHCMHUTCHMED$11.14+0.6%$11.40$9.77▼$19.50$1.93B0.2447,306 shs38,353 shsINDVIndivior$40.21-0.7%$38.59$15.00▼$42.81$4.94B0.861.78 million shs1.23 million shsITHInternational Tower Hill MinesC$2.98-2.0%C$3.24C$1.36▼C$4.94C$779.68M2.36183479,988 shs37,700 shsSOPHSOPHiA GENETICS$5.72+1.2%$5.18$2.92▼$6.30$474.01M0.96368,852 shs230,518 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHCMHUTCHMED+0.63%-4.38%+1.64%-26.76%-30.55%INDVIndivior-0.72%+0.55%+4.50%+21.96%+159.92%ITHInternational Tower Hill Mines-1.97%-13.12%+0.68%-16.29%+97.35%SOPHSOPHiA GENETICS+1.24%+7.12%+17.21%+15.32%+63.90%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHCMHUTCHMED 2.20Hold$15.3037.34% UpsideINDVIndivior 2.75Moderate Buy$40.290.19% UpsideITHInternational Tower Hill Mines 0.00N/AN/AN/ASOPHSOPHiA GENETICS 2.33Hold$7.5031.12% UpsideCurrent Analyst Ratings BreakdownLatest ITH, SOPH, INDV, and HCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2026INDVIndivior Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)7/7/2026HCMHUTCHMED Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$20.00 ➝ $17.006/29/2026HCMHUTCHMED Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)6/29/2026INDVIndivior Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold6/23/2026INDVIndivior Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Hold (C+)6/18/2026INDVIndivior BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$46.006/18/2026INDVIndivior BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$46.006/15/2026SOPHSOPHiA GENETICS BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.005/28/2026HCMHUTCHMED Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$13.605/6/2026INDVIndivior Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)5/6/2026SOPHSOPHiA GENETICS BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.00(Data available from 7/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHCMHUTCHMED$548.51M3.54$2.71 per share4.11$7.17 per share1.55INDVIndivior$1.24B3.96$2.70 per share14.89($0.78) per share-51.55ITHInternational Tower Hill MinesN/AN/AC$0.13 per share22.50C$0.69 per shareN/ASOPHSOPHiA GENETICS$77.27M6.21N/AN/A$0.69 per share8.29Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHCMHUTCHMED$456.91MN/AN/A39.79N/AN/AN/AN/A7/30/2026 (Estimated)INDVIndivior$210M$1.9520.629.42N/A19.44%-219.26%29.40%7/30/2026 (Estimated)ITHInternational Tower Hill Mines-C$2.36M-C$0.01N/AN/AN/AN/A-1.99%-3.65%N/ASOPHSOPHiA GENETICS-$79M-$0.52N/AN/AN/A-44.48%-62.74%-21.85%8/4/2026 (Estimated)Latest ITH, SOPH, INDV, and HCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026SOPHSOPHiA GENETICS-$0.2250N/AN/AN/A$21.62 millionN/A7/30/2026H1 2026HCMHUTCHMED$0.15N/AN/AN/A$306.40 millionN/A7/30/2026Q2 2026INDVIndivior$0.8770N/AN/AN/A$306.55 millionN/A5/8/2026Q1 2026ITHInternational Tower Hill MinesN/AC$0.01N/AC$0.01N/AN/A5/5/2026Q1 2026SOPHSOPHiA GENETICS-$0.2325-$0.27-$0.0375-$0.27$20.40 million$21.69 million4/30/2026Q1 2026INDVIndivior$0.64$0.96+$0.32$3.45$272.84 million$317.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHCMHUTCHMEDN/AN/AN/AN/AN/AINDVIndiviorN/AN/AN/AN/AN/AITHInternational Tower Hill MinesN/AN/AN/AN/AN/ASOPHSOPHiA GENETICSN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHCMHUTCHMED0.054.964.83INDVIndiviorN/A0.860.66ITHInternational Tower Hill MinesN/A238.0330.48SOPHSOPHiA GENETICS1.052.061.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHCMHUTCHMED8.82%INDVIndivior60.33%ITHInternational Tower Hill Mines9.16%SOPHSOPHiA GENETICS31.59%Insider OwnershipCompanyInsider OwnershipHCMHUTCHMED3.60%INDVIndivior0.74%ITHInternational Tower Hill Mines0.51%SOPHSOPHiA GENETICS4.88%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHCMHUTCHMED1,796174.47 million168.19 millionNot OptionableINDVIndivior1,051121.92 million121.02 millionNot OptionableITHInternational Tower Hill Mines220261.64 millionN/ANot OptionableSOPHSOPHiA GENETICS52083.89 million79.80 millionNot OptionableINDV, ITH, SOPH, and HCM HeadlinesRecent News About These CompaniesSOPHiA GENETICS (NASDAQ:SOPH) Chairman Jurgi Camblong Sells 17,685 SharesJuly 9, 2026 | insidertrades.comInsider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $93,376.80 in StockJuly 8, 2026 | marketbeat.comSOPHiA GENETICS (NASDAQ:SOPH) Insider Manuela Valente Sells 4,241 Shares of StockJuly 8, 2026 | insidertrades.comSOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $21,417.05 in StockJuly 7, 2026 | marketbeat.comSOPHiA GENETICS (NASDAQ:SOPH) CEO Ross Muken Sells 9,838 SharesJuly 7, 2026 | marketbeat.comJurgi Camblong Sells 22,486 Shares of SOPHiA GENETICS (NASDAQ:SOPH) StockJuly 7, 2026 | marketbeat.comSOPHiA GENETICS (NASDAQ:SOPH) CEO Jurgi Camblong Sells 50,069 SharesJune 30, 2026 | insidertrades.comInsider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $290,400.20 in StockJune 29, 2026 | marketbeat.comSOPHiA GENETICS Calls 2026 AGM as It Highlights Breakout 2025 GrowthJune 29, 2026 | theglobeandmail.comSOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 SharesJune 27, 2026 | insidertrades.comSOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares of StockJune 26, 2026 | marketbeat.comIs SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On?June 24, 2026 | finance.yahoo.comSOPHiA GENETICS Shareholders Back 2025 Results, Board Line-Up and Capital Changes at June 18 AGMJune 22, 2026 | tipranks.comSOPHiA GENETICS Publishes Results of the 2026 Annual General MeetingJune 22, 2026 | prnewswire.comSOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional SharesJune 19, 2026 | prnewswire.comSophia Genetics Shares Rise After $50M Stock Offering PricingJune 18, 2026 | marketwatch.comSOPHiA Genetics: Strong Growth Meets A Critical Execution PhaseJune 18, 2026 | seekingalpha.comSophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionJune 17, 2026 | benzinga.comSOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary SharesJune 16, 2026 | prnewswire.comSOPHiA GENETICS Announces Proposed Public Offering of Ordinary SharesJune 16, 2026 | prnewswire.comSOPHiA GENETICS names Ross Muken CEO and co-founder Camblong as chairman nomineeJune 11, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Could a Tesla-SpaceX Merger Be Closer Than Investors Think?By Sam Quirke | June 17, 2026Oracle’s Sell-Off Looks More Like a Mispricing Than a WarningBy Thomas Hughes | June 23, 2026Micron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026INDV, ITH, SOPH, and HCM Company DescriptionsHUTCHMED NASDAQ:HCM$11.14 +0.07 (+0.63%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$11.14 -0.01 (-0.04%) As of 07/13/2026 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.Indivior NASDAQ:INDV$40.21 -0.29 (-0.72%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$40.14 -0.07 (-0.17%) As of 07/13/2026 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder. The company also offers OPVEE nasal spray for opioid overdose reversal; and PERSERIS extended-release injectable suspension for the treatment of schizophrenia in adults. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that completed phase 1 clinical trial for the treatment of opioid use disorder (OUD); INDV-1000, a selective GABAb positive allosteric modulator, which is in pre-clinical development phase for the treatment of alcohol use disorder in collaboration with ADDEX therapeutics; INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc.; and CT-102, a digital therapeutic for the treatment of OUD in collaboration with Click Therapeutics. Further, the company is developing INDV-5004, a drinabant injection to treat acute cannabinoid overdose. It has a strategic partnership with Aelis Farma to develop AEF0117, a synthetic CB1 specific signaling inhibitor that is in phase 2B clinical trial for the treatment of cannabis use disorder. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.International Tower Hill Mines TSE:ITHC$2.98 -0.06 (-1.97%) As of 07/13/2026 04:00 PM EasternInternational Tower Hill Mines Ltd. has a 100% interest in its Livengood Gold Project located along the paved Elliott Highway, 70 miles north of Fairbanks, Alaska.SOPHiA GENETICS NASDAQ:SOPH$5.72 +0.07 (+1.24%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$5.61 -0.11 (-1.99%) As of 07/13/2026 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
